EP Patent

EP2292209A2 — Stable pharmaceutical composition comprising a pyramidine-sulfamide

Assigned to Actelion Pharmaceuticals Ltd · Expires 2011-03-09 · 15y expired

What this patent protects

The invention relates to stable pharmaceutical compositions comprising the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof

USPTO Abstract

The invention relates to stable pharmaceutical compositions comprising the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof

Drugs covered by this patent

Patent Metadata

Patent number
EP2292209A2
Jurisdiction
EP
Classification
—
Expires
2011-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Actelion Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.